Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

HIAA's Kahn Moving To FAH: Sees Little Chance Of Medicare Rx In 107th

  • News

Executive Summary

Health Insurance Association of America President Chip Kahn is moving to the Federation of American Hospitals in mid-June.

You may also be interested in...



HIAA is permanently Young

Health Insurance Association of America elevates interim President Donald Young to be permanent successor to Chip Kahn, who left the association in June to take the top spot at the Federation of American Hospitals (1"The Pink Sheet" May 28, p. 24)...

HIAA is permanently Young

Health Insurance Association of America elevates interim President Donald Young to be permanent successor to Chip Kahn, who left the association in June to take the top spot at the Federation of American Hospitals (1"The Pink Sheet" May 28, p. 24)...

PhRMA Staff Expansion May Help With New Medicare Rx Broker Baucus

PhRMA's federal affairs staff expansion includes a timely addition that should help the trade association work with incoming Finance Committee Chairman Baucus (D-Mont.).

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Tags:
Latest Headlines

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

See All
UsernamePublicRestriction

Register

PS037911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By